First Republic Investment Management, Inc. Point Biopharma Global Inc. Transaction History
First Republic Investment Management, Inc.
- $34.7 Billion
- Q3 2023
A detailed history of First Republic Investment Management, Inc. transactions in Point Biopharma Global Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 20,000 shares of PNT stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$0
Previous $181,000
26.52%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PNT
# of Institutions
1Shares Held
20KCall Options Held
0Put Options Held
0About POINT Biopharma Global Inc.
- Ticker PNT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 104,025,000
- Description
- POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...